{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:42:06Z","timestamp":1794328926088,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":133,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Foundation for Talented Scholars of Xuzhou Medical University","award":["RC20552421"],"award-info":[{"award-number":["RC20552421"]}]},{"name":"National Natural Science Foundation of China","award":["82500710"],"award-info":[{"award-number":["82500710"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Basic Research Program of Jiangsu","award":["BK20251042"],"award-info":[{"award-number":["BK20251042"]}]},{"name":"Basic Research Program of Jiangsu","award":["BK20241770"],"award-info":[{"award-number":["BK20241770"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03882-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:37:07Z","timestamp":1779752227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Irisin-integrin \u03b1V\/\u03b25 coupling of \u03b1-synuclein phagocytosis and clearance"],"prefix":"10.1186","volume":"23","author":[{"given":"Yihan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"s1","key":"3882_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/jpd-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinson\u2019s disease. 2018;8(s1):S3\u20138. https:\/\/doi.org\/10.3233\/jpd-181474.","journal-title":"J Parkinson\u2019s disease"},{"issue":"4","key":"3882_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3760\/cma.j.cn112137-20250529-01319","volume":"27","author":"Y Zhou","year":"2026","unstructured":"Zhou Y, Lu WZ, Cui BX, et al. [The diagnostic value of (18)F-AV-133 VMAT2 hybrid PET-MRI for cognitive impairment in Parkinson\u2019s disease]. Zhonghua yi xue za zhi. Jan. 2026;27(4):327\u201333. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20250529-01319.","journal-title":"Jan"},{"key":"3882_CR3","doi-asserted-by":"publisher","unstructured":"Scorziello A, Sirabella R, Sisalli MJ, et al. Mitochondrial Dysfunction in Parkinson\u2019s Disease: A Contribution to Cognitive Impairment? Int J Mol Sci Oct. 2024;25(21). https:\/\/doi.org\/10.3390\/ijms252111490.","DOI":"10.3390\/ijms252111490"},{"issue":"1","key":"3882_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10571-025-01576-8","volume":"30","author":"A Naskar","year":"2025","unstructured":"Naskar A, Sachin M, Sengupta S, et al. Fibrinogen and Complement Factor H Induce Parkinsonian and Cognitive Impairment-Like Features in Mice. Cell Mol Neurobiol May. 2025;30(1):54. https:\/\/doi.org\/10.1007\/s10571-025-01576-8.","journal-title":"Cell Mol Neurobiol May"},{"key":"3882_CR5","doi-asserted-by":"publisher","first-page":"1351555","DOI":"10.3389\/fsysb.2024.1351555","volume":"4","author":"C Denaro","year":"2024","unstructured":"Denaro C, Stephenson D, Muller M, Piccoli B, Azer K. Advancing precision medicine therapeutics for Parkinson\u2019s utilizing a shared quantitative systems pharmacology model and framework. Front Syst Biol. 2024;4:1351555. https:\/\/doi.org\/10.3389\/fsysb.2024.1351555.","journal-title":"Front Syst Biol"},{"issue":"11","key":"3882_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.12122\/j.issn.1673-4254.2021.11.07","volume":"20","author":"F Mu","year":"2021","unstructured":"Mu F, Chen X, Du X, Jiao Q, Bi M, Jiang H. [Regulatory mechanism of interferon regulatory factor 1 by alpha-synuclein in mouse Parkinson\u2019s disease model]. Nan Fang Yi Ke Da Xue Xue Bao Nov. 2021;20(11):1641\u20138. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2021.11.07.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao Nov"},{"issue":"10","key":"3882_CR7","doi-asserted-by":"publisher","first-page":"e3218","DOI":"10.1002\/brb3.3218","volume":"13","author":"D Pourzinal","year":"2023","unstructured":"Pourzinal D, Yang J, Sivakumaran K, et al. Longitudinal follow up of data-driven cognitive subtypes in Parkinson\u2019s disease. Brain Behav Oct. 2023;13(10):e3218. https:\/\/doi.org\/10.1002\/brb3.3218.","journal-title":"Brain Behav Oct"},{"key":"3882_CR8","doi-asserted-by":"publisher","unstructured":"Jan A, Goncalves NP, Vaegter CB, Jensen PH, Ferreira N. The Prion-Like Spreading of Alpha-Synuclein in Parkinson\u2019s Disease: Update on Models and Hypotheses. Int J Mol Sci Aug. 2021;3(15). https:\/\/doi.org\/10.3390\/ijms22158338.","DOI":"10.3390\/ijms22158338"},{"issue":"10","key":"3882_CR9","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/mds.28667","volume":"36","author":"R Isonaka","year":"2021","unstructured":"Isonaka R, Goldstein DS, Zhu W, et al. alpha-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson\u2019s Disease. Mov Disord Oct. 2021;36(10):2346\u201357. https:\/\/doi.org\/10.1002\/mds.28667.","journal-title":"Mov Disord Oct"},{"issue":"1","key":"3882_CR10","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1038\/s41598-022-21920-y","volume":"14","author":"AL Thomas","year":"2022","unstructured":"Thomas AL, Lehn MA, Janssen EM, Hildeman DA, Chougnet CA. Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease. Sci Rep Nov. 2022;14(1):19471. https:\/\/doi.org\/10.1038\/s41598-022-21920-y.","journal-title":"Sci Rep Nov"},{"issue":"9","key":"3882_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cns.13899","volume":"28","author":"F Yu","year":"2022","unstructured":"Yu F, Wang Y, Stetler AR, Leak RK, Hu X, Chen J. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther Sep. 2022;28(9):1279\u201393. https:\/\/doi.org\/10.1111\/cns.13899.","journal-title":"CNS Neurosci Ther Sep"},{"issue":"11","key":"3882_CR12","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1038\/s41401-025-01560-4","volume":"46","author":"YJ Liu","year":"2025","unstructured":"Liu YJ, Jia GR, Zhang SH, et al. The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis. Acta Pharmacol Sin Nov. 2025;46(11):2877\u201392. https:\/\/doi.org\/10.1038\/s41401-025-01560-4.","journal-title":"Acta Pharmacol Sin Nov"},{"issue":"1","key":"3882_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"13","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun Mar. 2020;13(1):1386. https:\/\/doi.org\/10.1038\/s41467-020-15119-w.","journal-title":"Nat Commun Mar"},{"key":"3882_CR14","doi-asserted-by":"publisher","first-page":"111676","DOI":"10.1016\/j.mce.2022.111676","volume":"15","author":"JJ Slate-Romano","year":"2022","unstructured":"Slate-Romano JJ, Yano N, Zhao TC. Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome. Mol Cell Endocrinol Jul. 2022;15:552:111676. https:\/\/doi.org\/10.1016\/j.mce.2022.111676.","journal-title":"Mol Cell Endocrinol Jul"},{"key":"3882_CR15","doi-asserted-by":"publisher","unstructured":"de Brito-Neto JG, Morais PLG, Cavalcanti J, Pinheiro FI, Guzen FP, Cobucci RN. Irisin as a Neuroprotective Agent in Parkinson\u2019s Disease: The Role of Physical Exercise in Modulating Dopaminergic Neurons. Pharmacy (Basel) Jan. 2026;13(1). https:\/\/doi.org\/10.3390\/pharmacy14010009.","DOI":"10.3390\/pharmacy14010009"},{"issue":"1","key":"3882_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12035-025-05312-7","volume":"15","author":"CL A Q","year":"2025","unstructured":"A Q CL. Critical Role of the Endothelial alphaV\/beta5 Integrin Receptor Signaling Pathway in Promoting Irisin-induced Hippocampal BDNF Expression. Mol Neurobiol Nov. 2025;15(1):50. https:\/\/doi.org\/10.1007\/s12035-025-05312-7.","journal-title":"Mol Neurobiol Nov"},{"issue":"8","key":"3882_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/neuonc\/noae065","volume":"5","author":"H Xie","year":"2024","unstructured":"Xie H, Jiang Y, Xiang Y, et al. Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia. Neuro Oncol Aug. 2024;5(8):1438\u201352. https:\/\/doi.org\/10.1093\/neuonc\/noae065.","journal-title":"Neuro Oncol Aug"},{"issue":"1","key":"3882_CR18","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1038\/s41467-025-57684-y","volume":"22","author":"GL McKinsey","year":"2025","unstructured":"McKinsey GL, Santander N, Zhang X, et al. Radial glia integrin avb8 regulates cell autonomous microglial TGFbeta1 signaling that is necessary for microglial identity. Nat Commun Mar. 2025;22(1):2840. https:\/\/doi.org\/10.1038\/s41467-025-57684-y.","journal-title":"Nat Commun Mar"},{"issue":"12","key":"3882_CR19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Oct. 2015;30(12):1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424.","journal-title":"Mov Disord Oct"},{"issue":"4","key":"3882_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41386-024-01994-0","volume":"50","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhao D, Zhou Y, et al. Cathepsin B modulates microglial migration and phagocytosis of amyloid beta in Alzheimer\u2019s disease through PI3K-Akt signaling. Neuropsychopharmacology Mar. 2025;50(4):640\u201350. https:\/\/doi.org\/10.1038\/s41386-024-01994-0.","journal-title":"Neuropsychopharmacology Mar"},{"key":"3882_CR21","doi-asserted-by":"publisher","unstructured":"Du S, Xiong S, Du X, Yuan TF, Peng B, Rao Y. Primary Microglia Isolation from Postnatal Mouse Brains. J Vis Exp Feb. 2021;25(168). https:\/\/doi.org\/10.3791\/62237.","DOI":"10.3791\/62237"},{"issue":"1","key":"3882_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12974-017-0877-7","volume":"8","author":"L Lin","year":"2017","unstructured":"Lin L, Desai R, Wang X, Lo EH, Xing C. Characteristics of primary rat microglia isolated from mixed cultures using two different methods. J Neuroinflammation May. 2017;8(1):101. https:\/\/doi.org\/10.1186\/s12974-017-0877-7.","journal-title":"J Neuroinflammation May"},{"issue":"5","key":"3882_CR23","doi-asserted-by":"publisher","first-page":"eadj7813","DOI":"10.1126\/sciadv.adj7813","volume":"2","author":"W Wang","year":"2024","unstructured":"Wang W, Li J, Cui S, et al. Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome. Sci Adv Feb. 2024;2(5):eadj7813. https:\/\/doi.org\/10.1126\/sciadv.adj7813.","journal-title":"Sci Adv Feb"},{"issue":"8","key":"3882_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.13703\/j.0255-2930.20250227-k0004","volume":"12","author":"M Li","year":"2025","unstructured":"Li M, Chen J, Chen M, et al. [Effects of electroacupuncture on cognitive impairment and mitophagy mediated by KIF5A\/Miro1 pathway in Parkinson\u2019s disease mice]. Zhongguo Zhen Jiu Aug. 2025;12(8):1111\u20139. https:\/\/doi.org\/10.13703\/j.0255-2930.20250227-k0004.","journal-title":"Zhongguo Zhen Jiu Aug"},{"issue":"28","key":"3882_CR25","doi-asserted-by":"publisher","first-page":"eadh1403","DOI":"10.1126\/sciadv.adh1403","volume":"14","author":"G Marino","year":"2023","unstructured":"Marino G, Campanelli F, Natale G, et al. Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson\u2019s disease restoring striatal synaptic plasticity. Sci Adv Jul. 2023;14(28):eadh1403. https:\/\/doi.org\/10.1126\/sciadv.adh1403.","journal-title":"Sci Adv Jul"},{"key":"3882_CR26","doi-asserted-by":"publisher","first-page":"105908","DOI":"10.1016\/j.parkreldis.2023.105908","volume":"117","author":"R Kim","year":"2023","unstructured":"Kim R, Lee TL, Lee H, et al. Effects of physical exercise interventions on cognitive function in Parkinson\u2019s disease: An updated systematic review and meta-analysis of randomized controlled trials. Parkinsonism Relat Disord Dec. 2023;117:105908. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105908.","journal-title":"Parkinsonism Relat Disord Dec"},{"key":"3882_CR27","doi-asserted-by":"publisher","first-page":"153597","DOI":"10.1016\/j.tox.2023.153597","volume":"494","author":"C Zhuo","year":"2023","unstructured":"Zhuo C, Xin J, Huang W, et al. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms. Toxicology Aug 1. 2023;494:153597. https:\/\/doi.org\/10.1016\/j.tox.2023.153597.","journal-title":"Toxicology Aug 1"},{"issue":"8","key":"3882_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.13703\/j.0255-2930.20210823-k0006","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Du ZH, Chen HY, Pan Y. [Effect of staged acupuncture on serum irisin level and neurological rehabilitation in patients with ischemic stroke]. Zhongguo Zhen Jiu Aug. 2022;12(8):857\u201362. https:\/\/doi.org\/10.13703\/j.0255-2930.20210823-k0006.","journal-title":"Zhongguo Zhen Jiu Aug"},{"issue":"1","key":"3882_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-023-00453-9","volume":"31","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu S, Hu Y, et al. Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson\u2019s disease. NPJ Parkinsons Dis Jan. 2023;31(1):13. https:\/\/doi.org\/10.1038\/s41531-023-00453-9.","journal-title":"NPJ Parkinsons Dis Jan"},{"key":"3882_CR30","doi-asserted-by":"publisher","first-page":"123088","DOI":"10.1016\/j.lfs.2024.123088","volume":"15","author":"R Qiu","year":"2024","unstructured":"Qiu R, Sun W, Su Y, et al. Irisin\u2019s emerging role in Parkinson\u2019s disease research: A review from molecular mechanisms to therapeutic prospects. Life Sci Nov. 2024;15:357:123088. https:\/\/doi.org\/10.1016\/j.lfs.2024.123088.","journal-title":"Life Sci Nov"},{"issue":"1","key":"3882_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s13063-022-06630-0","volume":"19","author":"M Nejati","year":"2022","unstructured":"Nejati M, Dehghan P, Khani M, Sarbakhsh P. The effect of Tribulus terrestris supplementation on inflammation, oxidative stress, and performance of recreational runners: study protocol for a randomized placebo-controlled trial. Trials Aug. 2022;19(1):689. https:\/\/doi.org\/10.1186\/s13063-022-06630-0.","journal-title":"Trials Aug"},{"issue":"2","key":"3882_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cell.2019.06.028","volume":"11","author":"H Kim","year":"2019","unstructured":"Kim H, Wrann CD, Jedrychowski M, et al. Irisin Mediates Effects on Bone and Fat via alphaV Integrin Receptors. Cell Jul. 2019;11(2):507\u20138. https:\/\/doi.org\/10.1016\/j.cell.2019.06.028.","journal-title":"Cell Jul"},{"issue":"1","key":"3882_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40035-025-00531-3","volume":"11","author":"T Li","year":"2025","unstructured":"Li T, Qiu T, Jiang F, Cai H, Le W. Microglia in the crosstalk between peripheral and central nervous systems in Parkinson\u2019s disease. Transl Neurodegener Dec. 2025;11(1):66. https:\/\/doi.org\/10.1186\/s40035-025-00531-3.","journal-title":"Transl Neurodegener Dec"},{"issue":"1","key":"3882_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41531-022-00361-4","volume":"6","author":"J Xu","year":"2022","unstructured":"Xu J, Ao YL, Huang C, et al. Harmol promotes alpha-synuclein degradation and improves motor impairment in Parkinson\u2019s models via regulating autophagy-lysosome pathway. NPJ Parkinsons Dis Aug. 2022;6(1):100. https:\/\/doi.org\/10.1038\/s41531-022-00361-4.","journal-title":"NPJ Parkinsons Dis Aug"},{"issue":"1","key":"3882_CR35","doi-asserted-by":"publisher","first-page":"42443","DOI":"10.1038\/s41598-025-26513-z","volume":"27","author":"Y Bai","year":"2025","unstructured":"Bai Y, Zang H, Chen Z, et al. Inhibiting TRPV4 improves alpha-synuclein degradation through autophagy-lysosomal pathway in the MPP(+)-induced cell model of parkinson\u2019s disease. Sci Rep Nov. 2025;27(1):42443. https:\/\/doi.org\/10.1038\/s41598-025-26513-z.","journal-title":"Sci Rep Nov"},{"issue":"1","key":"3882_CR36","doi-asserted-by":"publisher","first-page":"16091","DOI":"10.1038\/s41598-024-64131-3","volume":"12","author":"J George","year":"2024","unstructured":"George J, Shafiq K, Kapadia M, Kalia LV, Kalia SK. High frequency electrical stimulation reduces alpha-synuclein levels and alpha-synuclein-mediated autophagy dysfunction. Sci Rep Jul. 2024;12(1):16091. https:\/\/doi.org\/10.1038\/s41598-024-64131-3.","journal-title":"Sci Rep Jul"},{"issue":"1","key":"3882_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41531-023-00574-1","volume":"29","author":"DJ Dues","year":"2023","unstructured":"Dues DJ, Nguyen APT, Becker K, Ma J, Moore DJ. Hippocampal subfield vulnerability to alpha-synuclein pathology precedes neurodegeneration and cognitive dysfunction. NPJ Parkinsons Dis Aug. 2023;29(1):125. https:\/\/doi.org\/10.1038\/s41531-023-00574-1.","journal-title":"NPJ Parkinsons Dis Aug"},{"issue":"11","key":"3882_CR38","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1242\/jcs.018036","volume":"1","author":"AG Dupuy","year":"2008","unstructured":"Dupuy AG, Caron E. Integrin-dependent phagocytosis: spreading from microadhesion to new concepts. J Cell Sci Jun. 2008;1(11):1773\u201383. https:\/\/doi.org\/10.1242\/jcs.018036.","journal-title":"J Cell Sci Jun"},{"issue":"7","key":"3882_CR39","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1167\/iovs.13-12084","volume":"24","author":"D Gagen","year":"2013","unstructured":"Gagen D, Filla MS, Clark R, Liton P, Peters DM. Activated alphavbeta3 integrin regulates alphavbeta5 integrin-mediated phagocytosis in trabecular meshwork cells. Invest Ophthalmol Vis Sci Jul. 2013;24(7):5000\u201311. https:\/\/doi.org\/10.1167\/iovs.13-12084.","journal-title":"Invest Ophthalmol Vis Sci Jul"},{"issue":"1","key":"3882_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.exer.2011.11.007","volume":"94","author":"S Qin","year":"2012","unstructured":"Qin S, Rodrigues GA. Roles of alphavbeta5, FAK and MerTK in oxidative stress inhibition of RPE cell phagocytosis. Exp Eye Res Jan. 2012;94(1):63\u201370. https:\/\/doi.org\/10.1016\/j.exer.2011.11.007.","journal-title":"Exp Eye Res Jan"},{"issue":"35","key":"3882_CR41","doi-asserted-by":"publisher","first-page":"eadw0128","DOI":"10.1126\/sciadv.adw0128","volume":"29","author":"S Kessels","year":"2025","unstructured":"Kessels S, Trippaers C, Mertens M, et al. Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits. Sci Adv Aug. 2025;29(35):eadw0128. https:\/\/doi.org\/10.1126\/sciadv.adw0128.","journal-title":"Sci Adv Aug"},{"issue":"20","key":"3882_CR42","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1016\/j.cell.2021.09.007","volume":"30","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich H, Dansokho C, Mercan D, et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes. Cell Sep. 2021;30(20):5089\u2013e510621. https:\/\/doi.org\/10.1016\/j.cell.2021.09.007.","journal-title":"Cell Sep"},{"key":"3882_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2018.03.031","volume":"1","author":"Y Guan","year":"2018","unstructured":"Guan Y, Li Y, Zhao G, Li Y. HMGB1 promotes the starvation-induced autophagic degradation of alpha-synuclein in SH-SY5Y cells Atg 5-dependently. Life Sci Jun. 2018;1:202:1\u201310. https:\/\/doi.org\/10.1016\/j.lfs.2018.03.031.","journal-title":"Life Sci Jun"},{"issue":"5","key":"3882_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.200911078","volume":"6","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Livesey KM, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol Sep. 2010;6(5):881\u201392. https:\/\/doi.org\/10.1083\/jcb.200911078.","journal-title":"J Cell Biol Sep"},{"issue":"12","key":"3882_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","volume":"23","author":"D Tang","year":"2023","unstructured":"Tang D, Kang R, Zeh HJ, Lotze MT. The multifunctional protein HMGB1: 50 years of discovery. Nat Rev Immunol Dec. 2023;23(12):824\u201341. https:\/\/doi.org\/10.1038\/s41577-023-00894-6.","journal-title":"Nat Rev Immunol Dec"},{"issue":"2","key":"3882_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D. The mechanism of HMGB1 secretion and release. Exp Mol Med Feb. 2022;54(2):91\u2013102. https:\/\/doi.org\/10.1038\/s12276-022-00736-w.","journal-title":"Exp Mol Med Feb"},{"issue":"1","key":"3882_CR47","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41467-020-18443-3","volume":"11","author":"A Volchuk","year":"2020","unstructured":"Volchuk A, Ye A, Chi L, Steinberg BE, Goldenberg NM. Indirect regulation of HMGB1 release by gasdermin D. Nat Commun Sep. 2020;11(1):4561. https:\/\/doi.org\/10.1038\/s41467-020-18443-3.","journal-title":"Nat Commun Sep"},{"issue":"5","key":"3882_CR48","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/mds.25857","volume":"15","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH. The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord Apr. 2014;15(5):634\u201350. https:\/\/doi.org\/10.1002\/mds.25857.","journal-title":"Mov Disord Apr"},{"issue":"6","key":"3882_CR49","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JPD-240207","volume":"14","author":"A Bjorklund","year":"2024","unstructured":"Bjorklund A, Mattsson B. The AAV-alpha-Synuclein Model of Parkinson\u2019s Disease: An Update. J Parkinsons Dis. 2024;14(6):1077\u201394. https:\/\/doi.org\/10.3233\/JPD-240207.","journal-title":"J Parkinsons Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03882-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:09:46Z","timestamp":1791248986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03882-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3882"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03882-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"335"}}